Oligoarray comparative genomic hybridization in polycythemia vera and essential thrombocythemia
暂无分享,去创建一个
[1] A. Panani. Cytogenetic and molecular aspects of Philadelphia negative chronic myeloproliferative disorders: clinical implications. , 2007, Cancer letters.
[2] M. Stratton,et al. JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis. , 2007, The New England journal of medicine.
[3] D. Gilliland,et al. MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients. , 2006, Blood.
[4] P. Campbell,et al. Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study , 2005, The Lancet.
[5] P. Campbell,et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders , 2005, The Lancet.
[6] R. Kralovics,et al. Molecular pathogenesis of Philadelphia chromosome negative myeloproliferative disorders. , 2005, Blood reviews.
[7] E. Ikkala,et al. Essential thrombocythemia at diagnosis: causes of diagnostic evaluation and presence of positive diagnostic findings , 1998, Annals of Hematology.
[8] E. Ikkala,et al. Megakaryocyte and erythroid colony formation in essential thrombocythaemia and reactive thrombocytosis: diagnostic value and correlation to complications , 1993, British journal of haematology.